The article states it is no longer in short supply.
Even my little hospital in "podinkville" had Remdesivir early on and continues to use it.
Its very sad the care your friend received.
I worked for a company that compounded a drug combo under an FDA EA, we never had a limit. We produced thousands of doses per week. Never heard of a limit, once the EA is issued.
Would you have a link for the limit of use for EAs issued by FDA?
The US government should end the shortage of the antiviral drug remdesivir by eliminating Gilead’s monopoly, says a report from Public Citizen, a national non-profit organisation that represents consumers’ interests.
1
Remdesivir, an unapproved investigational drug that is used in patients with severe covid-19, is in short supply and rationed. Doctors and politicians at a press conference on 8 September called on the Trump administration to use existing laws to increase supplies of the drug by ending Gilead’s monopoly. This would allow other companies to make generic versions of the drug and permit imports of generic versions from foreign manufacturers. Gilead would earn licensing fees from generic manufacturers. Gilead has licensed some generic manufacturers to sell remdesivir in low and middle income countries, but the agreements are narrow and limited, says the report.
Covid-19: US should end Gilead’s monopoly on producing remdesivir, report says
I did not say there is an FDA EA for Remdesivir. Or that the supply is linked to government limits. It's just that production (and a monopoly by Gilead) are making supply outweighed by demand.
However, we don't even have emergency authorization by the FDA to use Regeneron, the antibody therapy the president is receiving. No one else gets that unless they're in a clinical trial or maybe at death's door:
Although Regeneron’s product
has not been authorized for emergency use by the Food and Drug Administration, companies can grant access to their experimental treatments through compassionate use, for example, if all other options have failed and a patient might die without trying the drug.
In an interview Friday afternoon, Regeneron’s chief executive, Dr. Leonard S. Schleifer, said Mr. Trump’s medical staff reached out to the company for permission to use the drug, and that it was cleared with the Food and Drug Administration.
“All we can say is that they asked to be able to use it, and we were happy to oblige,” he said. He said that so-called compassionate use cases — when patients are granted access to an experimental treatment outside of a clinical trial — are decided on a case-by-case basis and he is not the first patient to be granted permission to use the treatment this way. “When it’s the president of the United States, of course, that gets — obviously — gets our attention.”
Dr. Schleifer has known Mr. Trump casually for years, having been a member of his golf club in Westchester County.
A spokeswoman for Regeneron, Hala Mirza, said that for its coronavirus treatment, “our first priority is to maintain a sufficient supply in order to conduct rigorous clinical trials,” adding, “there is limited product available for compassionate use requests that are approved under certain exceptional circumstances on a case-by-case basis.”
President Trump Received Experimental Antibody Treatment
Emphasis by me.